This transcript has been edited for clarity. For more episodes, download the Medscape app or subscribe to the podcast on Apple Podcasts, Spotify, or your preferred podcast provider. Carol H. Wysham, ...
Analysis of claims data showed reduced utilization and costs among patients with nonintensively managed type 2 diabetes using self-monitoring of blood glucose compared with continuous glucose ...
CGM prescription rates were strikingly low in FQHCs - only 11% for type 1 diabetes and 1% for type 2 diabetes patients. Hispanic and Black patients had significantly lower odds of receiving CGM ...
In a recent study published in BMC Medicine, a team of South Korean researchers evaluated whether a smartphone application (app) for maintaining personal health records encouraged physical activity, ...
GALWAY, Ireland, Sept. 2, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA) regulatory milestones ...
Medications for type 2 diabetes address different aspects of blood sugar management and are tailored to individual health needs. Navigating type 2 diabetes treatment options can be complex, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback